Literature DB >> 32040553

Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis.

Rasha Khatib1, Stephanie Ross2, Sean Alexander Kennedy2, Ivan D Florez2,3, Thomas L Ortel4, Robby Nieuwlaat2, Ignacio Neumann2, Daniel M Witt5, Sam Schulman6,7, Veena Manja8, Rebecca Beyth9,10, Nathan P Clark11, Wojtek Wiercioch2, Holger J Schünemann2,6, Yuqing Zhang2,12.   

Abstract

Increasing evidence supports the safety and effectiveness of managing low-risk deep vein thrombosis (DVT) or pulmonary embolism (PE) in outpatient settings. We performed a systematic review to assess safety and effectiveness of managing patients with DVT or PE at home compared with the hospital. Medline, Embase, and Cochrane databases were searched up to July 2019 for relevant randomized clinical trials (RCTs), and prospective cohort studies. Two investigators independently screened titles and abstracts of identified citations and extracted data from relevant full-text papers. Risk ratios (RRs) were calculated, and certainty of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE). Seven RCTs (1922 patients) were included in meta-analyses on managing patients with DVT. Pooled estimates indicated decreased risk of PE (RR = 0.64; 95% confidence interval [CI], 0.44-0.93) and recurrent DVT (RR = 0.61; 95% CI, 0.42-0.90) for home management, both with moderate certainty of the evidence. Reductions in mortality and major bleeding were not significant, both with low certainty of the evidence. Two RCTs (445 patients) were included in meta-analyses on home management of low-risk patients with PE. Pooled estimates indicated no significant difference in all-cause mortality, recurrent PE, and major bleeding, all with low certainty of the evidence. Results of pooled estimates from 3 prospective cohort studies (234 patients) on home management of PE showed similar results. Our findings indicate that low-risk DVT patients had similar or lower risk of patient-important outcomes with home treatment compared with hospital treatment. In patients with low-risk PE, there was important uncertainty about a difference between home and hospital treatment.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32040553      PMCID: PMC7013254          DOI: 10.1182/bloodadvances.2019001223

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  30 in total

1.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

Review 2.  Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.

Authors:  Abdulaali R Almutairi; Lili Zhou; Walid F Gellad; Jeannie K Lee; Marion K Slack; Jennifer R Martin; Wei-Hsuan Lo-Ciganic
Journal:  Clin Ther       Date:  2017-06-28       Impact factor: 3.393

3.  Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study.

Authors:  H Boccalon; A Elias; J J Chalé; A Cadène; S Gabriel
Journal:  Arch Intern Med       Date:  2000-06-26

4.  Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis.

Authors:  Beng H Chong; Tim A Brighton; Ross I Baker; Peter Thurlow; Choon H Lee
Journal:  J Thromb Thrombolysis       Date:  2005-06       Impact factor: 2.300

5.  Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.

Authors:  Drahomir Aujesky; Pierre-Marie Roy; Franck Verschuren; Marc Righini; Joseph Osterwalder; Michael Egloff; Bertrand Renaud; Peter Verhamme; Roslyn A Stone; Catherine Legall; Olivier Sanchez; Nathan A Pugh; Alfred N'gako; Jacques Cornuz; Olivier Hugli; Hans-Jürg Beer; Arnaud Perrier; Michael J Fine; Donald M Yealy
Journal:  Lancet       Date:  2011-06-22       Impact factor: 79.321

6.  Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study.

Authors:  J A Heit; M D Silverstein; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  1999-03-08

7.  Early mobilisation in patients with acute deep vein thrombosis does not increase the risk of a symptomatic pulmonary embolism.

Authors:  A Romera-Villegas; M A Cairols-Castellote; R Vila-Coll; A Pérez-Piqueras Gómez; X Martí-Mestre; A Bonell-Pascual; O Lapiedra-Mur
Journal:  Int Angiol       Date:  2008-12       Impact factor: 2.789

8.  Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

Authors:  M M Koopman; P Prandoni; F Piovella; P A Ockelford; D P Brandjes; J van der Meer; A S Gallus; G Simonneau; C H Chesterman; M H Prins
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

9.  Outpatient Management of Emergency Department Patients With Acute Pulmonary Embolism: Variation, Patient Characteristics, and Outcomes.

Authors:  David R Vinson; Dustin W Ballard; Jie Huang; Mary E Reed; James S Lin; Mamata V Kene; Dana R Sax; Adina S Rauchwerger; David H Wang; D Ian McLachlan; Tamara S Pleshakov; Matthew A Silver; Victoria A Clague; Andrew S Klonecke; Dustin G Mark
Journal:  Ann Emerg Med       Date:  2017-12-13       Impact factor: 5.721

10.  Emergency Department Discharge of Pulmonary Embolus Patients.

Authors:  W Frank Peacock; Craig I Coleman; Deborah B Diercks; Samuel Francis; Christopher Kabrhel; Catherine Keay; Jeffrey A Kline; Jacob Manteuffel; Peter Wildgoose; Jim Xiang; Adam J Singer
Journal:  Acad Emerg Med       Date:  2018-06-11       Impact factor: 3.451

View more
  3 in total

1.  Implementation Science Opportunities in Cardiovascular Medicine.

Authors:  Karla I Galaviz; Geoffrey D Barnes
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-06-21

2.  Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial.

Authors:  Jeffrey A Kline; David H Adler; Naomi Alanis; Joseph R Bledsoe; Daniel M Courtney; James P d'Etienne; Deborah B Diercks; John S Garrett; Alan E Jones; David C Mackenzie; Troy Madsen; Andrew J Matuskowitz; Bryn E Mumma; Kristen E Nordenholz; Justine Pagenhardt; Michael S Runyon; William B Stubblefield; Christopher B Willoughby
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-06-21

3.  Listen to Your Heart (but DON'T Look at Theirs): Risk Assessment for Home Treatment of Pulmonary Embolism.

Authors:  Gregory Piazza
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.